Tolerability of neoadjuvant chemotherapy for esophageal cancer in elderly patients over 76 years of age

Although the Japan Clinical Oncology Group trial demonstrated that neoadjuvant chemotherapy (NAC) with 5-fluorouracil plus cis-diamminedichloroplatinum had significant survival benefits, it excluded elderly patients aged ≥ 76 years. Therefore, our study aimed to evaluate the tolerability of NAC in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Takafumi, Ishibashi, Yusuke, Tsujimoto, Hironori, Sugasawa, Hidekazu, Wakamatsu, Kotaro, Kouzu, Keita, Itazaki, Yujiro, Sugihara, Takao, Harada, Manabu, Ito, Nozomi, Kishi, Yoji, Ueno, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350567/
https://www.ncbi.nlm.nih.gov/pubmed/35967940
http://dx.doi.org/10.18999/nagjms.84.2.388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350567/
https://www.ncbi.nlm.nih.gov/pubmed/35967940
http://dx.doi.org/10.18999/nagjms.84.2.388

Ejemplares similares